Forte Biosciences (FBRX) Interest Coverage Ratio (2016 - 2020)
Forte Biosciences (FBRX) reported Interest Coverage Ratio of 2.68 for Q1 2020, up 88.02% year-over-year from 1.43 in Q2 2019, and up 43.43% quarter-over-quarter from 4.74 in Q4 2019.
Forte Biosciences (FBRX) Interest Coverage Ratio (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 5 years of Interest Coverage Ratio data on file, last reported at 2.68 in Q1 2020.
- Interest Coverage Ratio for Q1 2020 came in at 2.68, up 88.02% year-over-year; the trailing twelve-month figure through Dec 2020 was 61.22 (down 1084.53% YoY), and the FY2019 annual result was 1.06, up 93.2% from the prior year.
- Interest Coverage Ratio grew to 2.68 in Q1 2020 per FBRX's latest filing, from 4.74 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.92 in Q3 2018 and troughed at 36.81 in Q1 2018.
- A 5-year average of 14.62 and a median of 15.04 in 2016 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 108.49% in 2018 and fell as far as 165.1% in 2018.
- A 5-year view of Interest Coverage Ratio shows it stood at 14.96 in 2016, then tumbled by 82.72% to 27.33 in 2017, then advanced by 6.29% to 25.61 in 2018, then surged by 81.5% to 4.74 in 2019, then surged by 43.43% to 2.68 in 2020.
- Business Quant data shows FBRX's Interest Coverage Ratio at 2.68 in Q1 2020, 4.74 in Q4 2019, and 0.35 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -2.68 |
| Dec 31, 2019 | -4.74 |
| Sep 30, 2019 | -0.35 |
| Jun 30, 2019 | -0.82 |
| Mar 31, 2019 | -22.38 |
| Dec 31, 2018 | -25.61 |
| Sep 30, 2018 | 1.92 |
| Jun 30, 2018 | -14.02 |
| Mar 31, 2018 | -36.81 |
| Dec 31, 2017 | -27.33 |
| Sep 30, 2017 | -22.64 |
| Jun 30, 2017 | -17.48 |
| Mar 31, 2017 | -13.88 |
| Dec 31, 2016 | -14.96 |
| Sep 30, 2016 | -16.69 |
| Jun 30, 2016 | -15.09 |
| Mar 31, 2016 | -15.04 |